Terms: = Lymphoma AND TRIP11, Q15643, 9321, ENSG00000100815, Trip230, CEV14 AND Diagnosis
4 results:
1. A
Venable ER; Gagnon MF; Pitel BA; Palmer JM; Peterson JF; Baughn LB; Hoppman NL; Greipp PT; Ketterling RP; Patnaik MS; Kelemen K; Xu X
Cold Spring Harb Mol Case Stud; 2023 Feb; 9(1):. PubMed ID: 36627146
[TBL] [Abstract] [Full Text] [Related]
2. DF-MDA: An effective diffusion-based computational model for predicting miRNA-disease association.
Li HY; You ZH; Wang L; Yan X; Li ZW
Mol Ther; 2021 Apr; 29(4):1501-1511. PubMed ID: 33429082
[TBL] [Abstract] [Full Text] [Related]
3. Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement.
Shao H; Wang W; Song J; Tang G; Zhang X; Tang Z; Srivastava J; Shah B; Medeiros LJ; Zhang L
Leuk Res; 2020 Dec; 99():106460. PubMed ID: 33166908
[TBL] [Abstract] [Full Text] [Related]
4. A novel trip11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia.
Chung A; Hou Y; Ohgami RS; Von Gehr A; Fisk DG; Roskin KM; Li X; Gojenola L; Bangs CD; Arber DA; Fire AZ; Cherry AM; Zehnder JL; Gotlib J; Merker JD
Cancer Genet; 2017 Oct; 216-217():10-15. PubMed ID: 29025582
[TBL] [Abstract] [Full Text] [Related]
